Angeli Moeller's guest appearances

Angeli Moeller

The Alldus Podcast - AI in Action

The Harry Glorikian Show

Charles Fisher

Chris Hutchins

John Collins

Kevin Johnson

Richard Fox

John Glaser

Adam Wenchel

Rayid Ghani

Kraft Heinz

Sean McDermott

Matteo Franceschetti

Levi Strauss

Jason King

Azeem Azhar

Jenny Zhang

OwlTail

Angeli Moeller is a molecular biologist, a neuroscientist, a systems biologist, and a data scientist all rolled into one—which makes her a perfect example of the kind of multidisciplinary executive needed for this new digital health ecosystem defined by big data, AI, and machine learning. She's a founding member of the Alliance for Artificial Intelligence in Healthcare, does extensive work for the nonprofit rare disease advocacy group Rare-X, and has spent almost five years managing global data assets and IT partnerships at Bayer. At the beginning of 2021 she became the head of international pharma informatics for Roche, the world’s largest drug company. Harry caught up with her on Zoom in February, and the conversation started with the role of informatics at Roche, but quickly expanded to cover all the areas where deep learning and other forms of AI and data science are transforming drug discovery and healthcare, and what life sciences entrepreneurs need to do to get on board.Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac.2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings &amp; Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars.6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner.8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out.9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.TranscriptHarry Glorikian: Angeli Moeller is one of those people who seems like a born leader for the emerging field of data-driven healthcare and drug discovery. She’s a molecular biologist, a neuroscientist, a systems biologist, and a data scientist all rolled into one. Which makes her a perfect example of the kind of multidisciplinary executive I’ve been saying for years that we’re going to need in this new digital health ecosystem defined by big data, AI, and machine learning.She’s a founding member of the Alliance for Artificial Intelligence in Healthcare. She does extensive work for the nonprofit rare disease advocacy group Rare-X. She spent almost five years managing global data assets and IT partnerships at Bayer. And at the beginning of this year she became the head of international pharma informatics for Roche, the world’s largest drug company.Angeli and I seem to be on exactly the same wavelength about how Roche and other life sciences companies should be taking advantage of the huge leaps in computing power now available to them. And every time we see each other we end up geeking out about the enormous potential of today’s advances in artificial intelligence and machine learning to unlock revolutionary new treatments and even a new standard of care in our medical systems.Our last conversation happened back in February, and this time you get a chance to listen in.Harry Glor

Angeli Moeller is a molecular biologist, a neuroscientist, a systems biologist, and a data scientist all rolled into one—which makes her a perfect example of the kind of multidisciplinary executive needed for this new digital health ecosystem defined by big data, AI, and machine learning. She's a founding member of the Alliance for Artificial Intelligence in Healthcare, does extensive work for the nonprofit rare disease advocacy group Rare-X, and has spent almost five years managing global data assets and IT partnerships at Bayer. At the beginning of 2021 she became the head of international pharma informatics for Roche, the world’s largest drug company. Harry caught up with her on Zoom in February, and the conversation started with the role of informatics at Roche, but quickly expanded to cover all the areas where deep learning and other forms of AI and data science are transforming drug discovery and healthcare, and what life sciences entrepreneurs need to do to get on board.Please rate and review <a href="https://podcasts.apple.com/us/podcast/the-harry-glorikian-show/id1435939790" rel="nofollow" target="_blank">The Harry Glorikian Show on Apple Podcasts</a>! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac.2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings &amp; Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars.6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner.8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out.9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.TranscriptHarry Glorikian: Angeli Moeller is one of those people who seems like a born leader for the emerging field of data-driven healthcare and drug discovery. She’s a molecular biologist, a neuroscientist, a systems biologist, and a data scientist all rolled into one. Which makes her a perfect example of the kind of multidisciplinary executive I’ve been saying for years that we’re going to need in this new digital health ecosystem defined by big data, AI, and machine learning.She’s a founding member of the Alliance for Artificial Intelligence in Healthcare. She does extensive work for the nonprofit rare disease advocacy group Rare-X. She spent almost five years managing global data assets and IT partnerships at Bayer. And at the beginning of this year she became the head of international pharma informatics for Roche, the world’s largest drug company.Angeli and I seem to be on exactly the same wavelength about how Roche and other life sciences companies should be taking advantage of the huge leaps in computing power now available to them. And every time we see each other we end up geeking out about the enormous potential of today’s advances in artificial intelligence and machine learning to unlock revolutionary new treatments and even a new standard of care in our medical systems.Our last conversation happened back in February, and this time you get a chance to listen in.Harry Glor

Geeking Out about Data with Roche's Angeli Moeller

Today's guest is Angeli Moeller, Leader of AI program at Bayer Pharmaceuticals. Business Services serves as Bayer’s global in-house competence center for integrated business solutions and business support processes. Active in over 80 countries, its portfolio comprises the development, implementation and management of IT-based solutions and end-to-end processes as well as in-house management consulting. Angeli is also the Executive Officer and co-founder at the Alliance for Artificial Intelligence in Healthcare. AAIH is a global advocacy organization whose intent is to enable advancement and use of artificial intelligence in healthcare. AAIH believes that patients’ lives will be improved through investment, innovation and the thoughtful and responsible application of AI in the discovery and development of new therapies. In the episode, Angeli will discuss:  The goal at Bayer Pharmaceuticals  How AI is transforming patient treatment care  Challenging projects she has worked on  Her work with the Alliance for AI in Healthcare  Educating the public in Artificial Intelligence  How AI will continue to transform the healthcare sector 

Today's guest is Angeli Moeller, Leader of AI program at Bayer Pharmaceuticals. Business Services serves as Bayer’s global in-house competence center for integrated business solutions and business support processes. Active in over 80 countries, its portfolio comprises the development, implementation and management of IT-based solutions and end-to-end processes as well as in-house management consulting. Angeli is also the Executive Officer and co-founder at the Alliance for Artificial Intelligence in Healthcare. AAIH is a global advocacy organization whose intent is to enable advancement and use of artificial intelligence in healthcare. AAIH believes that patients’ lives will be improved through investment, innovation and the thoughtful and responsible application of AI in the discovery and development of new therapies. In the episode, Angeli will discuss: <ul> <li>The goal at Bayer Pharmaceuticals </li> <li>How AI is transforming patient treatment care </li> <li>Challenging projects she has worked on </li> <li>Her work with the Alliance for AI in Healthcare </li> <li>Educating the public in Artificial Intelligence </li> <li>How AI will continue to transform the healthcare sector </li></ul>

E40 Angeli Moeller, Leader of the AI program at Bayer Pharmaceuticals